BNP Paribas Financial Markets’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,393
| Closed | -$68.5K | – | 4490 |
|
|
2018
Q4 | $68.5K | Sell |
2,393
-2,226
| -48% | -$63.2K | ﹤0.01% | 2552 |
|
|
2018
Q3 | $129K | Buy |
4,619
+40
| +0.9% | +$1.13K | ﹤0.01% | 2612 |
|
|
2018
Q2 | $128K | Sell |
4,579
-45,811
| -91% | -$1.23M | ﹤0.01% | 2664 |
|
|
2018
Q1 | $1.25M | Buy |
50,390
+228
| +0.5% | +$5.55K | ﹤0.01% | 1598 |
|
|
2017
Q4 | $1.22M | Buy |
50,162
+41,400
| +472% | +$1.09M | ﹤0.01% | 1829 |
|
|
2017
Q3 | $242K | Sell |
8,762
-914
| -9% | -$24.4K | ﹤0.01% | 2365 |
|
|
2017
Q2 | $243K | Buy |
9,676
+6,624
| +217% | +$164K | ﹤0.01% | 2328 |
|
|
2017
Q1 | $81.9K | Sell |
3,052
-2,905
| -49% | -$80.3K | ﹤0.01% | 2565 |
|
|
2016
Q4 | $156K | Sell |
5,957
-2,743
| -32% | -$67.8K | ﹤0.01% | 2326 |
|
|
2016
Q3 | $217K | Buy |
8,700
+3,152
| +57% | +$73.5K | ﹤0.01% | 1696 |
|
|
2016
Q2 | $120K | Buy |
5,548
+2,026
| +58% | +$36.1K | ﹤0.01% | 2066 |
|
|
2016
Q1 | $52.8K | Sell |
3,522
-11,614
| -77% | -$195K | ﹤0.01% | 1984 |
|
|
2015
Q4 | $332K | Buy |
15,136
+1,839
| +14% | +$34.3K | ﹤0.01% | 1608 |
|
|
2015
Q3 | $210K | Buy |
13,297
+8,036
| +153% | +$129K | ﹤0.01% | 1923 |
|
|
2015
Q2 | $75.1K | Buy |
5,261
+3,811
| +263% | +$64.5K | ﹤0.01% | 2245 |
|
|
2015
Q1 | $25.1K | Buy |
+1,450
| New | +$25.6K | ﹤0.01% | 2265 |
|
|
2014
Q4 | – | Sell |
-3,711
| Closed | -$48.7K | – | 3650 |
|
|
2014
Q3 | $48.7K | Buy |
3,711
+3,590
| +2,967% | +$48.3K | ﹤0.01% | 2615 |
|
|
2014
Q2 | $1.74K | Buy |
+121
| New | +$1.58K | ﹤0.01% | 3190 |
|
|
2014
Q1 | – | Sell |
-775
| Closed | -$7.75K | – | 4007 |
|
|
2013
Q4 | $7.75K | Sell |
775
-15,542
| -95% | -$176K | ﹤0.01% | 2807 |
|
|
2013
Q3 | $215K | Sell |
16,317
-5,196
| -24% | -$68.2K | ﹤0.01% | 2193 |
|
|
2013
Q2 | $307K | Buy |
+21,513
| New | +$271K | ﹤0.01% | 1973 |
|
Other funds holding NXTM
BNP Paribas Financial Markets's NXTM Position: Q1 2019 in Review
BNP Paribas Financial Markets sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 2,393 shares — an estimated $68.5K sold.
BNP Paribas Financial Markets first reported a position in NXTM in Q2 2013 and held it in 21 quarters. The position peaked at $1.25M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- BNP Paribas Financial Markets reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 2,393 NxStage Medical Inc. shares in Q1 2019, an estimated $68.5K.
- BNP Paribas Financial Markets first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 21 quarters.
- BNP Paribas Financial Markets's NxStage Medical Inc. position peaked at $1.25M in Q1 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.